Orlando, FL – (NewMediaWire) – September 16, 2019 – REMSleep Holdings, Inc. (OTC PINK: RMSL) and its principals are pleased to announce the company has received Deltawave production and is preparing to introduce the new Deltawave CPAP interface to market. The company has completed the Deltawave instruction manual and is finishing up packaging for the Deltawave. The company is in early negotiations with potential distributors to introduce Deltawave to market.
REMSleep is also in negotiations with a CPAP machine manufacturer. REMSleep has been testing it’s new CPAP machine with the new Deltawave interface. The results have been remarkable. The new REMSleep CPAP machine and the new Deltawave interface pillows mask are a perfect fit and will have a huge impact on patient compliance to treatment. We predict the new CPAP machine will be available for market by the end of 2019.
As stated previously, REMSleep is in the process of molding the women’s version of Deltawave and we expect to have the women’s version available by the end of October. REMSleep is also in contract with a web development company for a new website. The new website is expected to be completed mid October.
REMSleep Holdings, Inc. was founded to design and manufacture devices and products for the treatment of sleep apnea and other respiratory conditions. With over 50 years of collective experience in CPAP therapy, the REMSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. REMSleep Holdings, Inc. has a new patent pending, innovative sleep apnea product that will meet multiple market needs and then be able to reach and address a large percentage of the patient population who continue to struggle with CPAP compliance.
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. No information in this press release should be construed as any indication whatsoever of the Company’s future revenues, results of operations or stock price. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.